Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancer Investigation|June 24, 2009
CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic valueYu-Xiang Liang, Hui-Chan He, Zhao-Dong Han, et al.
Pathology Oncology Research : POR|December 3, 2008
CD147 expression indicates unfavourable prognosis in prostate cancerZhao-dong Han, Xue-cheng Bi, Wei-jun Qin, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|August 7, 2008
Protective effect of ganoderan on renal damage in rats with chronic glomerulonephritisWei-De Zhong, Hui-Chan He, Ru-Biao Ou, et al.
The Journal of Surgical Research|March 17, 2009
Expression and clinical significance of CD147 in genitourinary carcinomasZhao-dong Han, Hui-chan He, Xue-cheng Bi, et al.
Oncology|October 15, 2008
CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancerWei-de Zhong, Zhao-dong Han, Hui-chan He, et al.
Cancer Epidemiology|May 21, 2010
Extracellular matrix metalloproteinase inducer expression has an impact on survival in human bladder cancerWei-De Zhong, Qing-Biao Chen, Yong-Kang Ye, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 1, 2012
Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomasXue-Cheng Bi, Jiu-Min Liu, Hui-Chang He, et al.
Biomed Research International|September 9, 2014
CC chemokine ligand 18 correlates with malignant progression of prostate cancerGuo Chen, Yu-xiang Liang, Jian-guo Zhu, et al.
Medical Oncology (Northwood, London, England)|December 17, 2013
Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancerYa-Qiang Huang, Zhao-Dong Han, Yu-Xiang Liang, et al.
Medical Oncology (Northwood, London, England)|January 5, 2012
Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysisZhao-dong Han, Yan-qiong Zhang, Hui-chan He, et al.
Pageof 3